SLC1A2 and amyotrophic lateral sclerosis: Hence, dysfunction of these two glutamate transporters is clearly implicated in neurodegenerative insults, in particular amyotrophic lateral sclerosis (ALS) [3], [4], a fatal disease characterized by the progressive and specific loss of motor neurons that has been correlated with deficient GLT-1 expression and activity [5], [6].